0001740010-18-000002.txt : 20180606 0001740010-18-000002.hdr.sgml : 20180606 20180606123008 ACCESSION NUMBER: 0001740010-18-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180606 DATE AS OF CHANGE: 20180606 EFFECTIVENESS DATE: 20180606 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Oxalo Therapeutics, Inc. CENTRAL INDEX KEY: 0001739172 IRS NUMBER: 824279147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-313980 FILM NUMBER: 18883316 BUSINESS ADDRESS: STREET 1: 1452 EAST 53RD STREET STREET 2: 2ND FLOOR CITY: CHICAGO STATE: IL ZIP: 60615 BUSINESS PHONE: 312-906-5342 MAIL ADDRESS: STREET 1: 1452 EAST 53RD STREET STREET 2: 2ND FLOOR CITY: CHICAGO STATE: IL ZIP: 60615 D 1 primary_doc.xml X0708 D LIVE 0001739172 Oxalo Therapeutics, Inc. 1452 EAST 53RD STREET 2ND FLOOR CHICAGO IL ILLINOIS 60615 312-906-5342 DELAWARE None None Corporation true 2018 Hatim Hassan 1452 East 53rd Street 2nd Floor Chicago IL ILLINOIS 60615 Executive Officer Director Yang Zheng 1452 East 53rd Street 2nd Floor Chicago IL ILLINOIS 60615 Director Other Technology Decline to Disclose 06b false 2018-06-05 true true true false 1 Indefinite 250000 Indefinite false 1 0 0 0 false Oxalo Therapeutics, Inc. /Catherine Larson/ Catherine Larson Attorney-In-Fact 2018-06-06